289 related articles for article (PubMed ID: 31784636)
1. Phosphoproteomic analysis sheds light on intracellular signaling cascades triggered by Formyl-Peptide Receptor 2.
Cattaneo F; Russo R; Castaldo M; Chambery A; Zollo C; Esposito G; Pedone PV; Ammendola R
Sci Rep; 2019 Nov; 9(1):17894. PubMed ID: 31784636
[TBL] [Abstract][Full Text] [Related]
2. Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949.
Lind S; Sundqvist M; Holmdahl R; Dahlgren C; Forsman H; Olofsson P
Biochem Pharmacol; 2019 Aug; 166():163-173. PubMed ID: 31085160
[TBL] [Abstract][Full Text] [Related]
3. Dual modulation of formyl peptide receptor 2 by aspirin-triggered lipoxin contributes to its anti-inflammatory activity.
Ge Y; Zhang S; Wang J; Xia F; Wan JB; Lu J; Ye RD
FASEB J; 2020 May; 34(5):6920-6933. PubMed ID: 32239559
[TBL] [Abstract][Full Text] [Related]
4. NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells.
Cattaneo F; Iaccio A; Guerra G; Montagnani S; Ammendola R
Free Radic Biol Med; 2011 Sep; 51(6):1126-36. PubMed ID: 21708247
[TBL] [Abstract][Full Text] [Related]
5. Biased allosteric modulation of formyl peptide receptor 2 leads to distinct receptor conformational states for pro- and anti-inflammatory signaling.
Zhang S; Gong H; Ge Y; Ye RD
Pharmacol Res; 2020 Nov; 161():105117. PubMed ID: 32768626
[TBL] [Abstract][Full Text] [Related]
6. WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A.
Cattaneo F; Parisi M; Ammendola R
FEBS Lett; 2013 May; 587(10):1536-42. PubMed ID: 23583448
[TBL] [Abstract][Full Text] [Related]
7. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of Formyl-Peptide Receptor 2 in human cancer cells.
Cattaneo F; Parisi M; Fioretti T; Sarnataro D; Esposito G; Ammendola R
Arch Biochem Biophys; 2016 Aug; 603():10-9. PubMed ID: 27177968
[TBL] [Abstract][Full Text] [Related]
9. The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase.
Holdfeldt A; Skovbakke SL; Winther M; Gabl M; Nielsen C; Perez-Gassol I; Larsen CJ; Wang JM; Karlsson A; Dahlgren C; Forsman H; Franzyk H
J Biol Chem; 2016 Sep; 291(38):19888-99. PubMed ID: 27422818
[TBL] [Abstract][Full Text] [Related]
10. Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.
Cattaneo F; Parisi M; Ammendola R
Int J Mol Sci; 2013 Apr; 14(4):7193-230. PubMed ID: 23549262
[TBL] [Abstract][Full Text] [Related]
11. Differential activation of formyl peptide receptor-like 1 by peptide ligands.
Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH
J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886
[TBL] [Abstract][Full Text] [Related]
12. Structural and conformational studies of biased agonism through formyl peptide receptors.
Liao Q; Ye RD
Am J Physiol Cell Physiol; 2022 May; 322(5):C939-C947. PubMed ID: 35385323
[TBL] [Abstract][Full Text] [Related]
13. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
[TBL] [Abstract][Full Text] [Related]
14. 3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Leopoldo M; Lucente E; Lacivita E; De Giorgio P; Quinn MT
Biochem Pharmacol; 2013 Feb; 85(3):404-16. PubMed ID: 23219934
[TBL] [Abstract][Full Text] [Related]
15. Non-peptide ligand binding to the formyl peptide receptor FPR2--A comparison to peptide ligand binding modes.
Stepniewski TM; Filipek S
Bioorg Med Chem; 2015 Jul; 23(14):4072-81. PubMed ID: 25882522
[TBL] [Abstract][Full Text] [Related]
16. Gastrin-releasing peptide/neuromedin B receptor antagonists PD176252, PD168368, and related analogs are potent agonists of human formyl-peptide receptors.
Schepetkin IA; Kirpotina LN; Khlebnikov AI; Jutila MA; Quinn MT
Mol Pharmacol; 2011 Jan; 79(1):77-90. PubMed ID: 20943772
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of ligand binding modes at the human formyl peptide receptor 2.
Chen T; Xiong M; Zong X; Ge Y; Zhang H; Wang M; Won Han G; Yi C; Ma L; Ye RD; Xu Y; Zhao Q; Wu B
Nat Commun; 2020 Mar; 11(1):1208. PubMed ID: 32139677
[TBL] [Abstract][Full Text] [Related]
18. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation Sites in Protein Kinases and Phosphatases Regulated by Formyl Peptide Receptor 2 Signaling.
Annunziata MC; Parisi M; Esposito G; Fabbrocini G; Ammendola R; Cattaneo F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471307
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential.
Maciuszek M; Cacace A; Brennan E; Godson C; Chapman TM
Eur J Med Chem; 2021 Mar; 213():113167. PubMed ID: 33486199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]